S.Biomedics Co., Ltd. (KOSDAQ:304360)
17,800
-870 (-4.66%)
At close: Nov 16, 2026
S.Biomedics Market Cap
S.Biomedics has a market cap or net worth of 220.46 billion as of November 16, 2026. It is the 21,548th most valuable company in the world and the 729th biggest in South Korea. Its market cap has decreased by 29.69% in one year.
Market Cap
220.46B
Enterprise Value
200.71B
Revenue
16.49B
Global Rank
Country Rank
#729 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 4, 2023, S.Biomedics's market cap has increased from 206.56B to 220.46B, an increase of 6.73%. That is a compound annual growth rate of 1.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 220.46B | -51.38% |
| Dec 30, 2025 | 453.47B | 123.16% |
| Dec 30, 2024 | 203.20B | 55.86% |
| Dec 28, 2023 | 130.38B | -36.88% |
| May 4, 2023 | 206.56B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curocell | 327.38B |
| AprilBio | 313.88B |
| ROKIT Healthcare | 281.30B |
| Inventage Lab | 251.91B |
| IMBiologics | 189.17B |
| IntoCell | 184.47B |
| HansBiomed | 172.56B |
| curacle co.,ltd. | 168.61B |